Stock listing

NASDAQ:FPRX Five Prime Therapeutics Inc Stock

Follow Five Prime Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:FPRX

$38.00 USD

Close on Apr 16, 2021 · No longer trades

Sep 18, 2013 to last close +190.5% · weekly closes, Sep 18, 2013 – Apr 16, 2021
Lowest – highest close
$1.86 – $60.89 USDSince Sep 18, 2013 · lowest Mar 18, 2020 · highest Nov 25, 2016

Delisted NASDAQ:FPRX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:FPRX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Five Prime Therapeutics Inc on 6ix

Decks
5 decks · latest Jan 15, 2021

Decks

DeckKindSlidesDate
ASCO Gastrointestinal Cancers Symposium 2021Conference15 slidesJan 15, 2021
Technical Presentation (November 2020)Technical14 slidesNov 10, 2020
ASCO 2018Conference15 slidesJun 4, 2018
Corporate Update (November 2017)Corporate update14 slidesNov 8, 2017
Investor Day (December 2016)Investor day77 slidesDec 8, 2016

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Franklin Berger
Other companies: Retension Pharmaceuticals, Inc. (Director · Since at least Oct 13, 2026); Atea Pharmaceuticals, Inc. (Director · Since at least Oct 29, 2020); ESSA Pharma Inc (Director · Since at least Oct 1, 2020); Kezar Life Sciences, Inc. (Director · Since at least Jun 20, 2018); Rain Oncology Inc (Director · Apr 22, 2021 – Jan 26, 2024 · Past); Atreca Inc (Director · Jun 19, 2019 – Jun 13, 2023 · Past); Tocagen Inc (Director · Apr 12, 2017 – Oct 4, 2019 · Past); Kineta Inc. (Director · Feb 10, 2016 – Jun 29, 2020 · Past); Immune Design Corp (Director · Jul 23, 2014 – Apr 2, 2019 · Past); Lineage Cell Therapeutics, Inc. (Director · May 13, 2013 – Aug 20, 2013 · Past); Emisphere Technologies Inc (Director · May 15, 2009 – May 15, 2009 · Past); Seagen Inc (Director · May 19, 2006 – Feb 21, 2014 · Past)
Director · Sep 17, 2013 – Apr 16, 2021 · Past
Brian Atwood
Other companies: CERo Therapeutics Holdings, Inc. (Director · Since at least Oct 5, 2021); Launch One Acquisition Corp. (Director · Jul 11, 2024 – Jul 11, 2024 · Past); Atreca Inc (Director · Jun 19, 2019 – Jun 13, 2023 · Past); CapForce Inc. (Director · May 4, 2015 – Jun 22, 2016 · Past); Flexion Therapeutics Inc (Director · Sep 10, 2014 – Sep 10, 2014 · Past); Immune Design Corp (Director · Jul 23, 2014 – Jan 4, 2016 · Past); Veracyte, Inc. (Director · Oct 29, 2013 – Jun 20, 2016 · Past); Clovis Oncology Inc (Director · Nov 15, 2011 – Jun 10, 2021 · Past); Trius Therapeutics Inc (Director · Aug 2, 2010 – Sep 11, 2013 · Past); Cadence Pharmaceuticals Inc (Director · Oct 24, 2006 – Mar 19, 2014 · Past); Pharmion Corp (Director · Jun 8, 2006 – Mar 7, 2008 · Past)
Director · Sep 17, 2013 – Jun 12, 2015 · Past
Fred E Cohen
Other companies: Kyverna Therapeutics, Inc. (Director · Since at least Feb 7, 2024); Intellia Therapeutics, Inc. (Director · Since at least Jan 23, 2019); CareDx, Inc. (Director · Since at least Jul 16, 2014); Progyny, Inc. (Director · Oct 24, 2019 – May 23, 2024 · Past); UroGen Pharma Ltd. (Director · Jan 1, 2019 – Aug 6, 2024 · Past); Roka Bioscience Inc (Director · Jul 16, 2014 – Jun 28, 2017 · Past); Tandem Diabetes Care, Inc. (Director · Nov 13, 2013 – Nov 15, 2018 · Past); Veracyte, Inc. (Director · Oct 29, 2013 – Oct 19, 2020 · Past); BioCryst Pharmaceuticals, Inc. (Director · Jul 22, 2013 – Jun 20, 2018 · Past); IQVIA Holdings, Inc. (Director · May 8, 2013 – May 8, 2013 · Past); Genomic Health Inc (Director · May 25, 2006 – Nov 8, 2019 · Past)
Director · Sep 17, 2013 – May 10, 2017 · Past
William R Ringo
Other companies: Assembly Biosciences, Inc. (Director · Since at least Jul 10, 2014); Sensei Biotherapeutics, Inc. (Director · Mar 8, 2022 – May 21, 2025 · Past); Immune Design Corp (Director · Jul 23, 2014 – Apr 2, 2019 · Past); Onyx Pharmaceuticals Inc (Director · Feb 3, 2011 – Oct 1, 2013 · Past); Sangamo Therapeutics, Inc. (Director · Apr 16, 2010 – Sep 20, 2017 · Past); Pfizer, Inc. (Senior Vice President · Apr 1, 2008 – Mar 31, 2010 · Past); Allos Therapeutics Inc (Director · Jan 5, 2007 – Jun 19, 2007 · Past); Inspire Pharmaceuticals Inc (Director · Jun 13, 2006 – Jun 8, 2007 · Past); Abgenix Inc (CEO and President, Director · Apr 1, 2006 – Apr 1, 2006 · Past); InterMune Inc (Director · Feb 23, 2006 – May 15, 2007 · Past)
Director · Oct 1, 2014 – Apr 5, 2021 · Past
Sheila Gujrathi
Other companies: Bolt Biotherapeutics, Inc. (Chief Strategy Officer · Since at least Oct 23, 2026); BlossomHill Therapeutics, Inc. (Director · Since at least Aug 6, 2026); Processa Pharmaceuticals, Inc. (Director · Since at least Jul 28, 2026); Ventyx Biosciences Inc (Director · Since at least Oct 20, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Turning Point Therapeutics Inc (Director · Apr 16, 2019 – Jun 15, 2020 · Past); Gossamer Bio, Inc. (President & CEO, Director · Feb 7, 2019 – Feb 14, 2020 · Past); Receptos Inc (Chief Medical Officer · May 8, 2013 – Aug 25, 2015 · Past)
Director · Dec 2, 2015 – May 10, 2018 · Past
Garry A Nicholson
Other companies: TScan Therapeutics, Inc. (Director · Since at least Jun 12, 2024); Day One Biopharmaceuticals Inc (Director · Since at least Sep 12, 2022); NextCure, Inc. (Director · Mar 25, 2020 – Jun 22, 2023 · Past); Turning Point Therapeutics Inc (Director · Jan 22, 2020 – Aug 17, 2022 · Past); G1 Therapeutics Inc (Director · Sep 12, 2018 – Sep 18, 2024 · Past); Tesaro Inc (Director · May 14, 2015 – Jan 22, 2019 · Past)
Director · May 10, 2017 – Apr 16, 2021 · Past
Carol A. Schafer
Other companies: Immunome, Inc. (Director · Since at least Jan 2, 2024); Kura Oncology, Inc. (Director · Since at least Jun 3, 2021); Repare Therapeutics Inc (Director · Since at least Jun 18, 2020); Insmed Incorporated (Director · Since at least Apr 1, 2020); Aceragen Inc. (Director · Dec 18, 2018 – Jun 23, 2022 · Past)
Director · May 14, 2019 – Apr 16, 2021 · Past
Mark McDade
Other companies: Tourmaline Bio Inc. (Director · Since at least May 6, 2021); Icosavax Inc (Director · Apr 1, 2022 – Jun 6, 2023 · Past); Aimmune Therapeutics Inc (Director · Aug 5, 2015 – Oct 10, 2020 · Past); Cytokinetics, Incorporated (Director · May 25, 2006 – May 21, 2009 · Past); PDL BioPharma Inc (CEO, Director · Jan 3, 2006 – Jul 20, 2007 · Past)
Director · Sep 17, 2013 – May 10, 2018 · Past
Francis Willard Sarena
Other companies: 89bio Inc (Chief Operating Officer · Since at least Jul 30, 2024); Apexigen Inc. (President and COO · Jul 29, 2022 – Aug 23, 2023 · Past); Facet Biotech Corp (VP Gen Counsel & Secy · Dec 9, 2008 – Apr 21, 2010 · Past); PDL BioPharma Inc (VP/Gen Counsel/Secy · Jan 10, 2008 – Sep 15, 2008 · Past)
Chief Strategy Officer · Sep 17, 2013 – Apr 1, 2021 · Past
Julie Hambleton
Other companies: Erasca, Inc. (Board Director · Since at least Jul 15, 2021); SpringWorks Therapeutics Inc (Director · Since at least May 20, 2020); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); IDEAYA Biosciences, Inc. (SVP, Chief Medical Officer · May 22, 2019 – Feb 21, 2020 · Past)
EVP & Chief Medical Officer · Sep 17, 2013 – Nov 11, 2015 · Past
All 28 people
PersonSeat
Kapil Dhingra
Other companies: LAVA Therapeutics NV (Director · Since at least Jan 1, 2025); CARGO Therapeutics, Inc. (Director · Since at least Apr 15, 2024); Black Diamond Therapeutics, Inc. (Director · Since at least Jan 19, 2021); Replimune Group, Inc. (Director · Since at least Jul 19, 2018)
Director · Dec 2, 2015 – Apr 16, 2021 · Past
Lewis T. Rusty Williams
Other companies: Protagonist Therapeutics, Inc. (Director, Co-Founder, Chairman · Since at least Jun 7, 2017); Arcellx Inc (Director · Feb 3, 2022 – Feb 8, 2022 · Past); Neurogene Inc. (Director · Aug 8, 2019 – May 11, 2021 · Past); Beckman Coulter Inc (Director · Oct 23, 2009 – Jun 30, 2011 · Past)
Director · Sep 17, 2013 – Sep 1, 2019 · Past
Linda Rubinstein
Other companies: Nektar Therapeutics (Chief Financial Officer · Since at least May 15, 2026); Adverum Biotechnologies Inc (CHIEF FINANCIAL OFFICER · Since at least Dec 12, 2022); Alector, Inc. (Interim Chief Financial Ofcr · Sep 8, 2021 – Sep 8, 2021 · Past); Solexa Inc (VP and CFO · Feb 2, 2006 – Jan 26, 2007 · Past)
Interim CFO · Apr 13, 2018 – Apr 13, 2018 · Past
Thomas Civik
Other companies: Pyxis Oncology, Inc. (Chief Executive Officer and Chairman of the Board · Since at least Oct 7, 2021); Repare Therapeutics Inc (Director · Since at least Sep 7, 2021); Foundation Medicine Inc (Chief Commercial Officer · Nov 13, 2017 – Jul 31, 2018 · Past)
President and CEO, Director · Apr 13, 2020 – Apr 16, 2021 · Past
David V Smith
Other companies: Codexis, Inc. (Director · Since at least Mar 1, 2016); Achieve Life Sciences, Inc. (Director · Aug 9, 2010 – May 26, 2016 · Past)
Executive Vice President & CFO · Nov 26, 2018 – Apr 16, 2021 · Past
Helen Collins
Other companies: Enliven Therapeutics, Inc. (Chief Medical Officer · Since at least Feb 23, 2023); Kura Oncology, Inc. (Director · Since at least Jul 28, 2021)
EVP and Chief Medical Officer · Mar 18, 2017 – Mar 31, 2021 · Past
Lori Lyons-Williams
Other companies: Contineum Therapeutics, Inc. (Director · Since at least Apr 4, 2024); RAPT Therapeutics Inc (Director · Since at least Nov 9, 2021)
Director · Jun 23, 2019 – Apr 16, 2021 · Past
Luis Borges
Other companies: Metagenomi Therapeutics, Inc. (Chief Scientific Officer · Feb 8, 2024 – Apr 1, 2024 · Past); Century Therapeutics, Inc. (Chief Scientific Officer · Jun 17, 2021 – Apr 3, 2023 · Past)
SVP, Research · Sep 8, 2016 – Mar 1, 2017 · Past
Marc Belsky
Other companies: Kezar Life Sciences, Inc. (Chief Financial Officer · Since at least Jun 20, 2018); Cell Genesys Inc (VP Finance & CAO · Dec 1, 2006 – Oct 14, 2009 · Past)
Senior Vice President and CFO · Sep 17, 2013 – Feb 26, 2018 · Past
Peder Jensen
Other companies: BioCryst Pharmaceuticals, Inc. (Director · May 3, 2011 – May 2, 2014 · Past); Acorda Therapeutics Inc (Director · Apr 19, 2011 – Jun 22, 2023 · Past)
Director · Sep 17, 2013 – Apr 16, 2021 · Past
Brian Russell Wong
Other companies: RAPT Therapeutics Inc (PRESIDENT AND CEO, Director · Since at least Oct 30, 2019)
SVP, Research · Jun 12, 2015 – Jun 12, 2015 · Past
William Michael Kavanaugh
Other companies: CytomX Therapeutics, Inc. (CSO, Head Res.&Non-Clin. Dev. · May 7, 2015 – Feb 14, 2020 · Past)
SVP & Chief Scientific Officer · Sep 17, 2013 – Aug 22, 2014 · Past
Aron Marc KnickerbockerPresident & CEO, Director · Sep 17, 2013 – Sep 1, 2019 · Past
Bryan IrvingEVP, Chief Scientific Officer · Sep 1, 2017 – May 15, 2019 · Past
David WhiteSee Remarks · Feb 28, 2019 – Apr 16, 2021 · Past
Kevin Paul BakerSVP, Development Sciences · Feb 1, 2016 – Feb 26, 2018 · Past
R Lee DouglasDirector · Sep 17, 2013 – Oct 12, 2016 · Past
Robert Steven SikorskiSVP and Chief Medical Officer · Jan 21, 2016 – Mar 1, 2017 · Past

Open People

Log in to ask 6ix AI your own questions about Five Prime Therapeutics Inc.